NICHI-IKO PHARMACEUTICAL

nichi-iko-pharmaceutical-logo

Nichi-Iko Pharmaceutical Co., Ltd. is the largest generic drug manufacturer in Japan by sales. In FY2014, it became the first Japanese generic medicine manufacturer to reach JPY100 billion in annual sales, and consolidated net sales in the fiscal year ended March 31, 2016 reached JPY143.5 billion. Since its establishment in 1965, Nichi-Iko has earned a reputation for operating at the forefront of quality assurance with premium quality generic pharmaceuticals. It has grown market share with an... extensive lineup of more than 1,000 commercialized products — the largest number among domestic pharmaceutical manufacturers — as well as strong relationships with wholesalers. Nichi-Iko’s development has been enhanced by six acquisitions and nine business alliances since the appointment of current President & CEO Yuichi Tamura in 2000. Nichi-Iko employs 1,142 people and operates seven production sites, one R&D facility, and four distribution centers throughout Japan. In Obelisk, its seventh Medium-term Business Plan for the three fiscal years from April 2016 through March 2019, Nichi-Iko aims to become a global Top 10 generics company, underpinned by three core strategies: Power of Expansion, Power of Production, and Power of Development.

#SimilarOrganizations #Financial #Website #More

NICHI-IKO PHARMACEUTICAL

Industry:
Biotechnology Manufacturing Pharmaceutical

Founded:
1965-01-01

Address:
Toyama-shi, Toyama, Japan

Country:
Japan

Website Url:
http://www.nichiiko.co.jp

Total Employee:
501+

Status:
Active

Contact:
+81764322121

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon Google Tag Manager Font Awesome Domain Not Resolving Apache


Similar Organizations

innocore-pharmaceuticals-logo

InnoCore Pharmaceuticals

InnoCore Pharmaceuticals is a biopharmaceutical drug delivery company.

Stock Details


Company's stock symbol is TYO:4541

Acquisitions List

Date Company Article Price
2016-07-11 Sagent Pharmaceuticals Sagent Pharmaceuticals acquired by Nichi-Iko Pharmaceutical 736 M USD

Official Site Inspections

http://www.nichiiko.co.jp Semrush global rank: 332.73 K Semrush visits lastest month: 182.67 K

Unable to get host informations!!!

Loading ...

More informations about "Nichi-Iko Pharmaceutical" on Search Engine